Table 2 Cox analysis of clinical variables contributing to overall survival

From: HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma

Analysis

Variable

B

SE

Waid

Df

Sig.

Exp(B)

95% Cl in Exp(B)

        

Down

Up

Step1

Age

.009

.016

.313

1

.576

1.009

.977

1.042

 

Sex

.108

.406

.070

1

.791

1.114

.502

2.470

 

Histopathological typing

–.274

.592

.215

1

.643

.760

.238

2.425

 

TNM stage

.645

.488

1.751

1

.186

1.907

.733

4.961

 

Therapies

–.811

.278

8.521

1

.004*

.445

.258

.766

 

Lymphatic metastasis

.101

.664

.023

1

.879

1.106

.301

4.064

 

HBP1

1.081

.402

7.227

1

.007*

2.947

1.340

6.480

Step2

Therapies

–.682

.250

7.447

1

.006*

.506

.310

.825

 

HBP1

1.020

.387

6.944

1

.008*

2.774

1.299

5.927

  1. HR = Exp (B) Hazard ratio p Values for clinical variables are from Cox regression after adjusting for each other
  2. *Bold values indicate statistically significant values
Back to article page